Antimyosin antibody imaging in clinical myocarditis and cardiomyopathy: principle and application
A Matsumori, T Yamada, S Sasayama - International journal of cardiology, 1996 - Elsevier
When cardiac myocytes fall into necrosis, their cell membrane integrity will be lost and
myosin heavy chains inside the cells will be exposed to the circulation. Then, antimyosin …
myosin heavy chains inside the cells will be exposed to the circulation. Then, antimyosin …
Emerging imaging techniques after cardiac transplantation
AK McDiarmid, S Plein, HJ Ross - The Journal of Heart and Lung …, 2016 - Elsevier
Improvements in survival after cardiac transplantation have in part been driven by improved
graft surveillance. Graft surveillance relies mainly on 3 techniques: coronary angiography …
graft surveillance. Graft surveillance relies mainly on 3 techniques: coronary angiography …
[PDF][PDF] PRELIMINARY STUDIES OF TECHNETIUM-99m-LABELED ANTIMYOSIN MONOCLONAL ANTIBODY: DEVELOPMENT OF RADIOPHARMACEUTICAL FOR …
GL de Castro Carvalho, PJ Spencer, E Muramoto… - repositorio.ipen.br
In the acute myocardium infarction, the myocytes cell membrane loses its integrity, allowing
the influx of extracellular macromolecules such as circulating antibody into the damaged …
the influx of extracellular macromolecules such as circulating antibody into the damaged …
Imciromab Pentetate (Monoclonal Antimyosin Antibody Fab) A Review of its Pharmacology and Clinical Potential in the Diagnosis of Cardiac Disorders
D Faulds, A Fitton - Clinical Immunotherapeutics, 1994 - Springer
Synopsis Imciromab (monoclonal antimyosin antibody Fab) pentetate is a murine
monoclonal antibody Fab (fragment antigen binding) derivative. It is specific for the human …
monoclonal antibody Fab (fragment antigen binding) derivative. It is specific for the human …
[CITATION][C] Charge modified antimyosin Fab for enhanced targeting of experimental acute myocardial infarction
BA Khaw, J Narula - … in cardiovascular diseases. Philadelphia: Lea & …, 1993